Total Payments
$50,453
2024 Payments
$12,785
Companies
54
Transactions
1,251
Medicare Patients
6,298
Medicare Billing
$5.8M
Payment Breakdown by Category
Other$25,835 (51.2%)
Food & Beverage$22,523 (44.6%)
Travel$1,172 (2.3%)
Consulting$750.00 (1.5%)
Education$172.61 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,523 | 1,227 | 44.6% |
| Honoraria | $16,835 | 10 | 33.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,000 | 4 | 17.8% |
| Travel and Lodging | $1,172 | 2 | 2.3% |
| Consulting Fee | $750.00 | 1 | 1.5% |
| Education | $172.61 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $20,007 | 96 | $0 (2023) |
| Amgen Inc. | $12,039 | 112 | $0 (2024) |
| Janssen Biotech, Inc. | $2,655 | 152 | $0 (2024) |
| ABBVIE INC. | $2,597 | 134 | $0 (2024) |
| PFIZER INC. | $2,387 | 196 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,711 | 102 | $0 (2024) |
| Genentech USA, Inc. | $998.05 | 66 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $897.11 | 46 | $0 (2023) |
| GlaxoSmithKline, LLC. | $891.09 | 47 | $0 (2024) |
| UCB, Inc. | $721.26 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,785 | 117 | Amgen Inc. ($10,166) |
| 2023 | $14,273 | 180 | Horizon Therapeutics plc ($10,205) |
| 2022 | $10,443 | 138 | Horizon Therapeutics plc ($8,342) |
| 2021 | $1,940 | 110 | Janssen Biotech, Inc. ($309.12) |
| 2020 | $2,547 | 82 | Horizon Therapeutics plc ($1,152) |
| 2019 | $2,957 | 198 | PFIZER INC. ($466.50) |
| 2018 | $3,350 | 244 | PFIZER INC. ($677.31) |
| 2017 | $2,158 | 182 | PFIZER INC. ($461.94) |
All Payment Transactions
1,251 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/10/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Rheumatology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $123.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $32.05 | General |
| 11/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $40.30 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Acute Care | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $14.52 | General |
| Category: Endocrinology | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,015 | 132,787 | $4.3M | $1.6M |
| 2022 | 24 | 1,648 | 57,440 | $3.3M | $1.1M |
| 2021 | 24 | 1,412 | 100,916 | $4.1M | $1.7M |
| 2020 | 20 | 1,223 | 100,740 | $3.1M | $1.4M |
Total Patients
6,298
Total Services
391,883
Medicare Billing
$5.8M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 8,475 | $579,690 | $281,148 | 48.5% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 33 | 26,351 | $1.0M | $276,781 | 27.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 157 | 15,060 | $413,728 | $274,661 | 66.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 20 | 24,570 | $292,774 | $196,011 | 66.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 47,200 | $591,888 | $184,818 | 31.2% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 22 | 6,030 | $772,598 | $159,034 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 476 | 1,326 | $252,144 | $137,821 | 54.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 45 | 240 | $96,485 | $28,895 | 29.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 74 | 356 | $47,601 | $19,918 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 128 | $35,840 | $19,239 | 53.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 73 | 73 | $29,737 | $13,644 | 45.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 261 | 261 | $26,100 | $11,529 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $25,068 | $9,897 | 39.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 195 | 690 | $34,736 | $8,262 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 75 | $9,750 | $5,468 | 56.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 25 | 147 | $24,620 | $3,804 | 15.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 48 | $9,728 | $3,067 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,680 | $2,370 | 88.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 21 | 85 | $5,230 | $1,207 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $2,145 | $1,114 | 51.9% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 15 | 19 | $3,321 | $970.70 | 29.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 17 | 85 | $10,200 | $583.04 | 5.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 51 | 647 | $5,176 | $540.52 | 10.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 21 | 110 | $5,500 | $480.50 | 8.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 112 | 589 | $8,470 | $298.05 | 3.5% |
About Dr. Arinola Dada, MD
Dr. Arinola Dada, MD is a Rheumatology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609871029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arinola Dada, MD has received a total of $50,453 in payments from pharmaceutical and medical device companies, with $12,785 received in 2024. These payments were reported across 1,251 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($22,523).
As a Medicare-enrolled provider, Dada has provided services to 6,298 Medicare beneficiaries, totaling 391,883 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Bellevue, WA
- Active Since 06/14/2005
- Last Updated 10/18/2010
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1609871029
Products in Payments
- KRYSTEXXA (Biological) $22,662
- XELJANZ (Drug) $1,995
- RINVOQ (Biological) $1,731
- Enbrel (Biological) $1,463
- COSENTYX (Biological) $1,225
- TREMFYA (Drug) $1,170
- BENLYSTA (Biological) $891.09
- ORENCIA (Biological) $880.12
- SIMPONI ARIA (Biological) $678.75
- TALTZ (Drug) $601.46
- SAPHNELO (Biological) $571.73
- Rituxan (Biological) $562.10
- Cimzia (Drug) $555.96
- Actemra (Biological) $435.95
- REMICADE (Biological) $426.71
- ACTHAR (Biological) $373.67
- STELARA (Biological) $336.22
- SKYRIZI (Biological) $308.20
- INFLECTRA (Biological) $259.42
- KEVZARA (Biological) $240.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Bellevue
Viviane Bunin, Md, MD
Rheumatology — Payments: $30,386
Rheumatology $30,386
Kent Ta, Md, MD
Rheumatology — Payments: $22,241
Rheumatology $22,241
Justin Putz, Do, DO
Rheumatology — Payments: $54.52
Rheumatology $54.52
Dr. Carl Brodie, M.d, M.D
Rheumatology — Payments: $38.84
Rheumatology $38.84
Dr. John Baldwin, Md, MD
Rheumatology
Rheumatology
Ashul Pandhi, M.d, M.D
Rheumatology
Rheumatology